Clinico-pathological features and the role of CD4/CD8 lymphocyte ratio in predicting response to neoadjuvant FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy in locally advanced gastric cancer
Volume 11 | Continuous 2025
We value your privacy
We use necessary cookies to run this website. With your consent, we may also use analytics, preference, functional, and marketing cookies.
